Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0677930 (
primary tumor
)
20,210
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Prostate cancer (PCa) is among the leading causes of cancer-related death in men. Androgen receptor (AR) signaling plays a seminal role in prostate development and homeostasis, and dysregulation of this pathway is intimately linked to prostate cancer pathogenesis and progression. Here, we identify the cytosolic NLR-related protein
NWD1
as a novel modulator of AR signaling. We determined that expression of
NWD1
becomes elevated during prostate cancer progression, based on analysis of
primary tumor
specimens. Experiments with cultured cells showed that
NWD1
expression is up-regulated by the sex-determining region Y (SRY) family proteins. Gene silencing procedures, in conjunction with transcriptional profiling, showed that
NWD1
is required for expression of PDEF (prostate-derived Ets factor), which is known to bind and co-regulate AR. Of note,
NWD1
modulates AR protein levels. Depleting
NWD1
in PCa cell lines reduces AR levels and suppresses activity of androgen-driven reporter genes.
NWD1
knockdown potently suppressed growth of androgen-dependent LNCaP prostate cancer cells, thus showing its functional importance in an AR-dependent tumor cell model. Proteomic analysis suggested that
NWD1
associates with various molecular chaperones commonly related to AR complexes. Altogether, these data suggest a role for tumor-associated over-expression of
NWD1
in dysregulation of AR signaling in PCa.
...
PMID:The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling. 2468 25